Copyright
©The Author(s) 2017.
World J Gastrointest Pathophysiol. Aug 15, 2017; 8(3): 117-126
Published online Aug 15, 2017. doi: 10.4291/wjgp.v8.i3.117
Published online Aug 15, 2017. doi: 10.4291/wjgp.v8.i3.117
Component | Placebo (n = 13) | Probiotic (n = 15) |
Total calories (kcal) | 1630.4 ± 134.4 | 1644.7 ± 94.5 |
Total caloric needs (% of RMR) | 72% | 79% |
Servings (#) | 6.3 ± 0.5 | 6.4 ± 0.4 |
Fat (g) | 88.8 ± 7.3 | 89.6 ± 5.1 |
Fat (kcal) | 799.3 ± 6.6 | 806.4 ± 46.3 |
Saturated fat (g) | 31.7 ± 2.6 | 32.0 ± 1.8 |
Trans fat (g) | 0 | 0 |
Protein (g) | 69.8 ± 5.8 | 70.4 ± 4.0 |
Carbohydrate (g) | 145.9 ± 12.0 | 147.2 ± 8.5 |
Carbohydrate (kcal) | 583.6 ± 48.1 | 588.8 ± 33.8 |
Cholesterol (mg) | 152.3 ± 12.5 | 153.6 ± 8.8 |
Sodium (mg) | 2911.9 ± 240.0 | 2937.4 ± 168.8 |
- Citation: McFarlin BK, Henning AL, Bowman EM, Gary MA, Carbajal KM. Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers. World J Gastrointest Pathophysiol 2017; 8(3): 117-126
- URL: https://www.wjgnet.com/2150-5330/full/v8/i3/117.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v8.i3.117